Get the Stockscreener App
32.52
2.70%
+0.71
OrthoPediatrics corp stock is currently priced at $32.52, with a 24-hour trading volume of 98,099.
It has seen a +2.70% increased in the last 24 hours and a +19.28% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $31.56 pivot point. If it approaches the $32.68 resistance level, significant changes may occur.
Previous Close:
$31.81
Open:
$32.4
24h Volume:
98,099
Market Cap:
$781.85M
Revenue:
$148.73M
Net Income/Loss:
$-20.97M
P/E Ratio:
361.33
EPS:
0.09
Net Cash Flow:
$-46.03M
1W Performance:
+7.96%
1M Performance:
+19.28%
6M Performance:
+21.59%
1Y Performance:
-32.42%
1D Range:
$32.40
$33.52
52W Range:
$23.10
$48.47
OrthoPediatrics corp Stock (KIDS) Company Profile
Name
OrthoPediatrics corp
Sector
Industry
Phone
574-268-6379
Address
2850 Frontier Drive, Warsaw, IN
OrthoPediatrics corp Stock (KIDS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-14-21 | Reiterated | Needham | Buy |
| Apr-02-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jun-19-19 | Initiated | Needham | Buy |
| Feb-20-19 | Initiated | JMP Securities | Mkt Outperform |
| Jul-05-18 | Reiterated | Piper Jaffray | Overweight |
View All
OrthoPediatrics corp Stock (KIDS) Latest News
OrthoPediatrics Corp. to Report First Quarter 2024 Financial Results on May 7, 2024
GlobeNewswire Inc.
The Analyst Verdict: OrthoPediatrics In The Eyes Of 6 Experts
Benzinga
OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 8th Annual International Children’s Spine Symposium (ICSS)
GlobeNewswire Inc.
OrthoPediatrics Corp. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
GlobeNewswire Inc.
Cracking The Code: Understanding Analyst Reviews For OrthoPediatrics
Benzinga
OrthoPediatrics (KIDS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks Investment Research
OrthoPediatrics corp Stock (KIDS) Financials Data
OrthoPediatrics corp (KIDS) Revenue 2024
KIDS reported a revenue (TTM) of $148.73 million for the quarter ending December 31, 2023, a +21.62% rise year-over-year.
OrthoPediatrics corp (KIDS) Net Income 2024
KIDS net income (TTM) was -$20.97 million for the quarter ending December 31, 2023, a -1,767% decrease year-over-year.
OrthoPediatrics corp (KIDS) Cash Flow 2024
KIDS recorded a free cash flow (TTM) of -$46.03 million for the quarter ending December 31, 2023, a -44.76% decrease year-over-year.
OrthoPediatrics corp (KIDS) Earnings per Share 2024
KIDS earnings per share (TTM) was -$0.92 for the quarter ending December 31, 2023, a -3,167% decline year-over-year.
About OrthoPediatrics corp
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, locking cannulated blades, locking proximal femurs, spica tables, response spine systems, and pediguards; bandloc, a sub-laminar banding system; and sports medicine and other products, such as anterior cruciate ligament and medial patellofemoral ligament systems. Its products are used in the pediatric trauma and deformity procedures, as well as scoliosis procedures for the treatment of spinal deformity. The company serves pediatric orthopedic market, as well as caregivers. OrthoPediatrics Corp. was founded in 2007 and is headquartered in Warsaw, Indiana.
0.85%
Cap:
|
Volume (24h):